Progressive Diagnosis of Chronic Myeloproliferative Neoplasms: A Case Study
S King, F Tardy, J Lam - American Society for Clinical …, 2019 - clsjournal.ascls.org
Chronic myeloproliferative neoplasms are hematologic diseases characterized by the clonal
proliferation of peripheral blood components. A series of laboratory tests are required for …
proliferation of peripheral blood components. A series of laboratory tests are required for …
Myeloproliferative Neoplasms
JA Thorson, HY Wang - Diagnostic Molecular Pathology in Practice: A …, 2011 - Springer
A 59-year-old female was referred to the hematology department for evaluation of persistent
erythrocytosis. Two years prior to this visit, she was seen by her primary care physician with …
erythrocytosis. Two years prior to this visit, she was seen by her primary care physician with …
A diagnostic dilemma: Chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia: A case report and review of the literature
MJ Misialek, L Pechet - Acta haematologica, 1997 - karger.com
There exists a great deal of overlap between many myelodysplastic syndromes and
myeloproliferative disorders. This is most evident in the spectrum of disorders classified …
myeloproliferative disorders. This is most evident in the spectrum of disorders classified …
Diversity of Bone Marrow Findings in Chronic Myelomonocytic Leukemia
LL Yavorkovsky, LY Ryauzova, DY Solovey… - Leukemias, 1993 - Springer
Since the early 1970s, when chronic myelomonocytic leukemia (CMML) was described as a
novel type of leukemia, this entity has drawn our particular interest. At the beginning the …
novel type of leukemia, this entity has drawn our particular interest. At the beginning the …
[HTML][HTML] Myeloproliferative disorders: A retrospective cohort study
RM Ali, V Masoud - Annals of Medicine and Surgery, 2021 - Elsevier
Objectives This study was aimed to identify the number, shape and distribution of
megakaryocytes and to recognize blast cells and its location. Further, to identify presence of …
megakaryocytes and to recognize blast cells and its location. Further, to identify presence of …
Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
B Frisch, R Bartl, R Burkhardt, K Jäger - Haematologia, 1984 - europepmc.org
The chronic myeloproliferative disorders (MPD) are well characterized clinical entities
comprising polycythaemia vera (PV), idiopathic thrombocythaemia (IT)(also called …
comprising polycythaemia vera (PV), idiopathic thrombocythaemia (IT)(also called …
[PDF][PDF] Myeloproliferative neoplasms: an overview
K Finnegan - Clinical Laboratory Science, 2011 - clsjournal.ascls.org
The myleproliferative neoplasms (MPNs) are a closely related group of clonal stem cell
hematologic blood disorders characterized by an increase in one or more cell lines of the …
hematologic blood disorders characterized by an increase in one or more cell lines of the …
CMML: a biologically distinct myeloproliferative disease.
J Cortes - Current hematology reports, 2003 - europepmc.org
Chronic myelomonocytic leukemia (CMML) is a myeloproliferative disorder with unique
characteristics. Dysplasia is usually present in the bone marrow, thus CMML has usually …
characteristics. Dysplasia is usually present in the bone marrow, thus CMML has usually …
Peripheral blood findings in chronic myeloproliferative disorders
M Imbert - Clinics in laboratory medicine, 2002 - labmed.theclinics.com
Chronic myeloproliferative diseases (CMPD) are clonal hematopoietic disorders1, 2, 19, 20,
28 that arise in a marrow stem cell and induce, at least at the initial phase of the disease, an …
28 that arise in a marrow stem cell and induce, at least at the initial phase of the disease, an …
Chronic myelomonocytic leukemia: single entity or heterogeneous disorder?: a prospective multicenter study of 100 patients
GF de Cytogenetique Hematologique - Cancer Genetics and Cytogenetics, 1991 - Elsevier
To investigate the prognostic factors in chronic myelomonocytic leukemia (CMMoL), and to
determine the importance of cytogenetic abnormalities at diagnosis and during evolution, a …
determine the importance of cytogenetic abnormalities at diagnosis and during evolution, a …